Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026).
Saved in:
| Title: | Phase II Trial of Ribociclib Plus Letrozole in Women With Recurrent Low-Grade Serous Carcinoma of the Ovary, Fallopian Tube, or Peritoneum: A GOG Partners Trial (GOG 3026). |
|---|---|
| Authors: | Slomovitz BM; Mount Sinai Medical Center, Miami, FL., Weroha SJ; Mayo Clinic, Rochester, MN., Deng W; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Chon HS; Moffitt Cancer Center, Tampa, FL., Podder V; Mount Sinai Medical Center, Miami, FL., Jenkins Vogel MT; Endeavor Health, NorthShore University Health System, Evanston, IL., Backes F; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Thomas ED; Oklahoma Cancer Specialists and Research Institute, LLC (OCSRI), Tulsa, OK., Chen LM; University of California, San Francisco (UCSF), San Francisco, CA., Tenney ME; Northside Hospital, Atlanta, GA., Westin SN; University of Texas MD Anderson Cancer Center, Houston, TX., Markham MJ; University of Florida College of Medicine, UF Health Cancer Center, Gainesville, FL., Miller DS; University of Texas Southwestern Medical Center, Dallas, TX., Edelson MI; Jefferson Abington Hospital, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA., Muller CY; University of New Mexico Comprehensive Cancer Center, Albuquerque, NM., Callahan MJ; St Vincent Health, Inc d/b/a Ascension St Vincent, Indianapolis, IN., Holman LL; Stephenson Cancer Center, University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, OK., Liu JR; Trinity Health-St. Joseph Mercy Hospital, Ypsilanti, MI., Teplinsky E; Valley Health System, Paramus, NJ., Kamat A; Houston Methodist Sugar Land Hospital, Houston, TX., Guy M; Miami Valley Hospital South, Centerville, OH., Chern JY; Moffitt Cancer Center, Tampa, FL., Lea J; University of Texas Southwestern Medical Center, Dallas, TX., Murphy M; University of Florida College of Medicine, UF Health Cancer Center, Gainesville, FL., Choong GM; Mayo Clinic, Rochester, MN., Moore ED; Endeavor Health, NorthShore University Health System, Evanston, IL., Alvarez EA; University of California, San Francisco (UCSF), San Francisco, CA., Rodgers WH; New York Presbyterian Queens, Flushing, NY., O'Malley DM; The Ohio State University, James Cancer Center, Columbus, OH., Copeland LJ; The Ohio State University Comprehensive Cancer Center, Columbus, OH., Herzog TJ; University of Cincinnati, University of Cincinnati Cancer Center, Cincinnati, OH., Coleman RL; Texas Oncology, US Oncology Network, The Woodlands, TX., Gershenson DM; University of Texas MD Anderson Cancer Center, Houston, TX. |
| Source: | Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2026 Jan 20; Vol. 44 (3), pp. 153-163. Date of Electronic Publication: 2025 Dec 12. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
